Cargando…

MFAP2 Promotes the Proliferation of Cancer Cells and Is Associated With a Poor Prognosis in Hepatocellular Carcinoma

BACKGROUNDS: Microfibril-associated protein 2 (MFAP2) is an extracellular matrix protein that regulates the function of microfibrils by interacting with fibrillin. MFAP2 has been reported to play an important role in metabolic diseases and has been shown to be significantly overexpressed in head and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiang, Cheng, Ye, Wu, Fan, Sun, Haoyao, Zheng, Wubin, Jiang, Wei, Shi, Junfeng, Ma, Shijie, Cao, Hongyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724263/ https://www.ncbi.nlm.nih.gov/pubmed/33280519 http://dx.doi.org/10.1177/1533033820977524

Ejemplares similares

circCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD‐L1 through NF‐κB pathway
por: Wu, Fan, et al.
Publicado: (2021)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway
por: Yao, Li-wen, et al.
Publicado: (2020)

Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma
por: Liu, Xincheng, et al.
Publicado: (2017)

MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy: MFAP2 and autophagy-induced OSCC progression
por: Zhang, Hao, et al.
Publicado: (2023)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
por: Zhang, Ning, et al.
Publicado: (2022)

MFAP5 promotes basal-like breast cancer progression by activating the EMT program
por: Wu, Yanmei, et al.
Publicado: (2019)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment
por: Wang, Junfeng, et al.
Publicado: (2021)

CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma
por: Zhong, Xiaoping, et al.
Publicado: (2019)

Oncogene TUBA1C promotes migration and proliferation in hepatocellular carcinoma and predicts a poor prognosis
por: Wang, Ji, et al.
Publicado: (2017)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins
por: Ying, Hanning, et al.
Publicado: (2018)

Insulin-Like Growth Factor Binding Protein-2 Promotes Proliferation and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ma, Yang, et al.
Publicado: (2020)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions
por: Wulf-Johansson, Helle, et al.
Publicado: (2013)

Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Chen, Yuanyuan, et al.
Publicado: (2016)

Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma
por: Li, Junxiang, et al.
Publicado: (2016)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Yi-Wei, et al.
Publicado: (2014)

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2020)

The spliceosome-associated protein Mfap1 binds to VCP in Drosophila
por: Rode, Sandra, et al.
Publicado: (2017)

Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma
por: Tang, Fenfen, et al.
Publicado: (2022)

Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma
por: Sun, Guoqiang, et al.
Publicado: (2022)

MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer
por: Dong, Si Yang, et al.
Publicado: (2020)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Hypoxia-induced MFAP5 Promotes Tumor Migration and Invasion via AKT Pathway in Head and Neck Squamous Cell Carcinoma
por: Xu, Qiaoshi, et al.
Publicado: (2020)

Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma
por: Shi, Chao, et al.
Publicado: (2019)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tglk1i01907e2oje7450ec00l6